dual gip/glp-1 receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Back to routine postings! Here's

(3) Combination therapies: combining oxidative cell death inducers with conventional treatments, such as chemotherapy and radiotherapy, can synergistically enhance treatment effectiveness, potentially overcoming drug resistance and improving patient outcomes

The method of embodiments39 or 40, wherein each medium chain fatty acid independently comprises 6 to 12 carbon atoms in the carbon chain

J Clin Psychiatry 56:519525 Bruijn JA, van den Broek W, van Hulst A, Van der Mast R, van de Wetering B, Moleman P, Mulder P (1996) A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients

A separate study published in August 2025 found patients prescribed semaglutide or tirzepatide for Type 2 diabetes had an increased risk of NAION and other optic nerve disorders, but the overall risk was very low

hCG may also be used to restore spermatogenesis in m hypogonadal hypogonadism or steroid induced impairment of spermatogenesis